1. Home
  2. FPI vs KROS Comparison

FPI vs KROS Comparison

Compare FPI & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Farmland Partners Inc.

FPI

Farmland Partners Inc.

HOLD

Current Price

$10.37

Market Cap

430.1M

Sector

Real Estate

ML Signal

HOLD

Logo Keros Therapeutics Inc.

KROS

Keros Therapeutics Inc.

HOLD

Current Price

$20.10

Market Cap

655.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FPI
KROS
Founded
2013
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
430.1M
655.9M
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
FPI
KROS
Price
$10.37
$20.10
Analyst Decision
Buy
Analyst Count
0
12
Target Price
N/A
$22.20
AVG Volume (30 Days)
587.3K
969.1K
Earning Date
10-29-2025
11-05-2025
Dividend Yield
2.30%
N/A
EPS Growth
296.76
N/A
EPS
1.27
1.57
Revenue
$52,990,000.00
$246,718,000.00
Revenue This Year
N/A
$6,876.34
Revenue Next Year
N/A
N/A
P/E Ratio
$8.17
$13.23
Revenue Growth
N/A
37798.31
52 Week Low
$9.37
$9.12
52 Week High
$12.87
$22.55

Technical Indicators

Market Signals
Indicator
FPI
KROS
Relative Strength Index (RSI) 71.85 57.16
Support Level $9.65 $20.73
Resistance Level $10.13 $21.75
Average True Range (ATR) 0.15 1.06
MACD 0.08 -0.03
Stochastic Oscillator 89.77 57.76

Price Performance

Historical Comparison
FPI
KROS

About FPI Farmland Partners Inc.

Farmland Partners Inc owns and seeks to acquire high-quality farmland throughout North America. The company is an internally managed real estate company which owns and contracts farmland and storage facilities located across the United States. Majority of the properties in its portfolio are used to grow primary crops, such as corn, soybeans, wheat, rice and cotton, and rest to produce specialty crops, such as almonds, pictachios, citrus, avacados, strawberies, and edible beans. The company generates its revenues through the rent it receives from its tenants.

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Share on Social Networks: